|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o AaiPharma Inc., of Wilmington, N.C., extended and amended its pending solicitation from holders of its 11 percent senior subordinated notes relating to certain proposed amendments to and waivers of the indenture governing the notes. All holders of record who submit valid and unrevoked consents prior to noon EST, today will receive the consent fee of $10 in cash per $1,000 principal amount of notes for which consents have been delivered. Holders who previously have delivered consents need not take any further action in order to receive the fee.
o Advanced Biotherapy Inc., of Woodland Hills, Calif., reported the launch of a Phase I FDA-approved trial to initially ...
Related newspaper, magazine, and journal articles:
|
|
Article: Applied Biosystems, Roche Molecular Systems, Bio-Rad ...
Business Wire;
February 13, 2006 ;
700+ words
... ... and Roche Molecular Systems against MJ Research (acquired by Bio-Rad in 2004 ... brought by Applera against Bio-Rad and MJ Research for infringement of Applera's Real ... patents has been amended to include the MJ Research thermal cyclers that were subject to ...
|
|